Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sorrento Therapeutics, Inc. | Director | Common Stock | 235K | $189K | $0.80 | Sep 3, 2021 | Direct |
Celularity Inc | Director | Class A Common Stock | 236K | $58.8K | $0.25 | Jun 14, 2023 | Direct |
Celularity Inc | Director | Stock Option (Right to Buy) | 278K | Jun 14, 2023 | Direct | ||
Sorrento Therapeutics, Inc. | Director | Stock Options | 0 | Sep 3, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CELU | Celularity Inc | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
CELU | Celularity Inc | Aug 16, 2022 | 2 | $0 | 4 | Aug 18, 2022 | Director |
CELU | Celularity Inc | Jul 13, 2022 | 2 | $0 | 4 | Jul 15, 2022 | Director |
WAVS | Western Acquisition Ventures Corp. | Jan 11, 2022 | 0 | $0 | 3 | Jan 11, 2022 | Director |
CELU | Celularity Inc | Sep 9, 2021 | 1 | $0 | 4 | Sep 13, 2021 | Director |
SRNEQ | Sorrento Therapeutics, Inc. | Sep 3, 2021 | 4 | $785K | 4 | Sep 3, 2021 | Director |
SRNEQ | Sorrento Therapeutics, Inc. | Aug 30, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Director |
CELU | Celularity Inc | Jul 16, 2021 | 2 | $0 | 4 | Jul 20, 2021 | Director |
CELU | GX Acquisition Corp. | Jul 16, 2021 | 0 | $0 | 3 | Jul 16, 2021 | Director |